RK
Global Head, Epidemiology, AbbVie
Ryan Kilpatrick is the head of epidemiology at AbbVie, Inc. Prior to this, he held roles in Amgen, GSK and Baxalta. His primary interest is in use of pharmacoepidemiology in drug safety and to support drug development across the product lifecycle.
Member PRAC, Pharmacovigilance and Epidemiology Department, University of Dundee
Daniel Morales is a General Practitioner and Epidemiologist at the University of Dundee and current member of the EMA Pharmacovigilance Risk Assessment Committee. His research interests include the use of real world data to support medicines regulation and safer prescribing, and has...
Read More →
Assistant Professor Medical Informatics, Erasmus Medical Center
Peter Rijnbeek is Assistant Professor at the Erasmus University Medical Center in Rotterdam where he is leading the Health Data Science group at the Department of Medical Informatics (www.healthdatascience.nl). He is co-leading the European Health Data and Evidence Network (EHDEN...
Read More →
Professor of Medicine and Epidemiology, Harvard Medical School and Brigham & Women's Hospital
Sebastian Schneeweiss, MD, ScD, is a Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital. His research focuses on the comparative effectiveness and safety of biopharmaceuticals...
Read More →
Professor, Julius Global Health, University Medical Center Utrecht
Miriam Sturkenboom is a professor in Observational Data Analysis, a pharmacoepidemiologist, currently working at the Julius Global Health group of University Medical Center Utrecht in the Netherlands. She is a past president of ISPE. Her research focuses on knowledge discovery from...
Read More →
